Related Experiment Video
Updated: Feb 16, 2026

A Practical and Novel Method to Extract Genomic DNA from Blood Collection Kits for Plasma Protein Preservation
Published on: May 18, 2013
Plasma SCF/c-kit Levels in Patients with Dipper and Non-Dipper Hypertension
Hai-Lan Zhong1, Chong-Li Xu1, Guang-Sheng Chen1
1Department of Cardiology, Jiangning Hospital of Nanjing, Nanjing 211100, China.
Insights
Peripheral plasma stem cell factor (SCF)/c-kit levels are elevated in non-dipper hypertension patients. These higher SCF/c-kit levels correlate with increased blood pressure and inflammatory markers, suggesting a role in hypertension severity.
Area of Science:
- Cardiovascular Research
- Hypertension Pathophysiology
- Biomarker Discovery
Background:
- Hypertension is a major cardiovascular risk factor.
- Blood pressure dipping patterns (dipper vs. non-dipper) influence cardiovascular outcomes.
- The role of stem cell factor (SCF)/c-kit in different hypertension phenotypes requires further investigation.
Purpose of the Study:
- To investigate the relationship between peripheral plasma stem cell factor (SCF)/c-kit levels and dipper versus non-dipper hypertension.
- To explore the correlation of SCF/c-kit with 24-hour ambulatory blood pressure monitoring (ABPM) parameters and inflammatory markers.
Main Methods:
- Cross-sectional study of 247 newly diagnosed hypertensive patients.
- Classification into dipper and non-dipper groups based on 24-hour ABPM.
- Measurement of peripheral plasma SCF, c-kit, tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6) using enzyme-linked immunosorbent assays.
Main Results:
- Non-dipper hypertensive patients exhibited significantly higher peripheral plasma SCF and c-kit levels compared to dippers.
- SCF/c-kit levels showed a significant positive correlation with 24-hour mean systolic blood pressure (MSBP) and mean diastolic blood pressure (MDBP).
- Elevated SCF/c-kit levels were also positively correlated with plasma TNF-α and IL-6 concentrations.
Conclusions:
- Peripheral plasma SCF/c-kit levels are elevated in non-dipper hypertension.
- SCF/c-kit may serve as a potential biomarker for hypertension severity and associated inflammation.
- These findings highlight a potential link between the SCF/c-kit pathway and the non-dipper phenotype in hypertension.
Abstract:
Objective The aim of this study was to investigate the relationship between peripheral plasma stem cell factor (SCF)/c-kit levels and the types of dipper and non-dipper hypertension in hypertensive patients. Methods This cross-sectional study included newly diagnosed hypertensive patients who underwent 24-hour ambulatory blood pressure monitor (ABPM) between January 2009 and 2012 in Jiangning city. Patients were divided into the dipper group and the non-dipper group according to ABPM measurements. The levels of SCF and its receptor c-kit, tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) in peripheral blood were measured via enzyme-linked immunosorbent assays. The serum levels of glucose and lipid were examined as well. The levels of SCF/c-kit were compared between the dippers and the non-dippers; and their correlation with 24-hour mean systolic blood pressure (MSBP), 24-hour mean diastolic blood pressure (MDBP), TNF-α and IL-6 were investigated using linear regression analyses statistically. Results A total of 247 patients with newly diagnosed hypertension were recruited into the study, including 116 non-dippers and 131 dippers. The levels of peripheral plasma SCF were higher in non-dipper group (907.1±52.7 ng/L vs. 778.7±44.6 ng/L; t=2.837, P<0.01), and the levels of c-kit were higher in non-dipper group too (13.2±1.7 μg/L vs 9.57±1.4 μg/L; t=2.831, P<0.01). Linear regression analysis revealed that SCF/c-kit levels were significantly positively correlated with MSBP, MDBP, plasma TNF-α, and IL-6 levels (all P<0.01). Conclusions Peripheral plasma SCF/c-kit levels are higher in patients with non-dipper hypertension than those with dipper one, and significantly correlate with 24-hour MSBP, 24-hour MDBP, serum TNF-α and IL-6 levels.
Related Concept Videos
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Leveling Effect
High-Level and Low-Level Awareness

